Thieno[2,3-c]pyridine-3-carboxylicacid, 2-amino-4,5,6,7-tetrahydro-6-(phenylmethyl)-, ethyl ester, hydrochloride(1:1) cas no:25913-34-2

NameThieno[2,3-c]pyridine-3-carboxylicacid, 2-amino-4,5,6,7-tetrahydro-6-(phenylmethyl)-, ethyl ester, hydrochloride(1:1)
CAS25913-34-2
SynonymsThieno[2,3-c]pyridine-3-carboxylicacid, 2-amino-4,5,6,7-tetrahydro-6-(phenylmethyl)-, ethyl ester,monohydrochloride (9CI); Thieno[2,3-c]pyridine-3-carboxylic acid,2-amino-6-benzyl-4,5,6,7-tetrahydro-, ethyl ester, monohydrochloride (8CI);2-Amino-3-ethoxycarbonyl-6-benzyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridinehydrochloride; Tinoridine hydrochloride; Y-3642 HCl
EINECS(EC#)247-342-9
Molecular FormulaC17H20 N2 O2 S . Cl H
Molecular Weight352.87

Safety

Moderately toxic by ingestion and intraperitoneal routes. An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of SO_x, NO_x, and HCl.

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
mouse	LD50	intraperitoneal	510mg/kg (510mg/kg)	BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: ATAXIA	Yakugaku Zasshi. Journal of Pharmacy. Vol. 90, Pg. 1439, 1970.
mouse	LD50	oral	1601mg/kg (1601mg/kg)		Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 2, Pg. 1028, 1974.
mouse	LD50	subcutaneous	> 10200mg/kg (10200mg/kg)		Drugs in Japan Vol. 6, Pg. 463, 1982.
rat	LD50	intraperitoneal	1350mg/kg (1350mg/kg)	BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: ATAXIA	Yakugaku Zasshi. Journal of Pharmacy. Vol. 90, Pg. 1439, 1970.
rat	LD50	oral	1200mg/kg (1200mg/kg)	BEHAVIORAL: TREMOR BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION	Yakugaku Zasshi. Journal of Pharmacy. Vol. 99, Pg. 240, 1979.
rat	LD50	subcutaneous	> 10200mg/kg (10200mg/kg)	SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE"	Yakugaku Zasshi. Journal of Pharmacy. Vol. 90, Pg. 1439, 1970.